Clonidine topical gel: Completed Phase IIb enrollment

BioDelivery completed enrollment of 125 patients in a double-blind, placebo-controlled, U.S. Phase IIb trial evaluating clonidine topical gel applied thrice daily for 12 weeks. BioDelivery has exclusi...